No FDA approval of any psychedelic therapy within 30 days.

The FDA (the US drug regulator) won't approve any psychedelic-based treatment in the next 30 days. This matters because approval would be the green light for doctors to legally prescribe these treatments — and that moment is still a while away.

No psychedelic candidate has an active PDUFA target date within the next month, and FDA approvals are preceded by publicly tracked advisory committee meetings and acceptance announcements — none pending. Near-term approval is administratively implausible.